Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04859764 · ClinicalTrials.gov registry record · NA
Effect of Reparel Knee Sleeve With Knee Injection
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04859764 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants.
The verdict
NCT04859764, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goals of treating knee osteoarthritis (OA) is to improve or maintain quality of life, mobility and function, pain relief, and improve inflammation. The different treatment options for knee OA have been extensively studied and implemented, but the optimum treatment is still undecided. There is a belief that anti-inflammatory sleeve technology may be beneficial in treating knee OA. The purpose of this study is to determine if the Reparel™ knee sleeve results in superior mobility, functionality, and pain outcomes as compared to a placebo knee sleeve in managing knee OA.
Interventions
- DRUG Corticosteroid injection
- DEVICE Reparel knee sleeve
- DEVICE Placebo knee sleeve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-06-29 |
| Est. Completion | 2025-12-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04859764
The ClinicalTrials.gov registry entry for NCT04859764 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Corticosteroid injection is the first listed.
NCT04859764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04859764 about?
NCT04859764 is a clinical study titled "Effect of Reparel Knee Sleeve With Knee Injection". The goals of treating knee osteoarthritis (OA) is to improve or maintain quality of life, mobility and function, pain relief, and improve inflammation. The different treatment options for knee OA have been extensively studied and implemented, but the optimum treatment is still undecided. There is a ...
What is the current status of trial NCT04859764?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-06-29. Estimated completion is 2025-12-03.
What interventions are being tested in trial NCT04859764?
The interventions under investigation include: Corticosteroid injection (DRUG), Reparel knee sleeve (DEVICE), Placebo knee sleeve (DEVICE).
Who is sponsoring clinical trial NCT04859764?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.